CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) IPO - S-1 Filing, Stock & Insider Activity
CTT PHARMACEUTICAL HOLDINGS, INC. IPO - Status & S-1 Filing
- Ticker: CTTH
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-12-30
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 6,250,000
- SEC CIK: 0001035422 · View the S-1 on SEC EDGAR →
CTT PHARMACEUTICAL HOLDINGS, INC. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every CTTH SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC. trades under the ticker CTTH. InsiderAlpha tracks 13 primary SEC Form 4 filings from 1 reporting insider for CTTH since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001035422 |
Recent CTTH Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 62.9K | $0.04 | $3K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | Director | P - Open-market purchase | 200.0K | $0.04 | $8K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 7.0K | $0.06 | $420 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 6.8K | $0.06 | $409 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 44.1K | $0.04 | $2K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 15.8K | $0.04 | $553 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | A - Grant or award | 750.0K | $0.04 | $30K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 8.0K | $0.03 | $240 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 39.6K | $0.03 | $990 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 16.1K | $0.03 | $402 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 82.2K | $0.05 | $4K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | A - Grant or award | 150.0K | $0.06 | $9K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 10.0K | $0.07 | $649 | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 23.3K | $0.06 | $1K | SEC | |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | P - Open-market purchase | 54.8K | $0.03 | $1K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH). Updated in real time as new filings are submitted to the SEC.
Recent Insider Filings
- - CTT PHARMACEUTICAL HOLDINGS, INC. (Director)
- - CTT PHARMACEUTICAL HOLDINGS, INC. (CEO)
- - CTT PHARMACEUTICAL HOLDINGS, INC. (CEO)
- - CTT PHARMACEUTICAL HOLDINGS, INC. (CEO)
- - CTT PHARMACEUTICAL HOLDINGS, INC. (CEO)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CTTH insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CTTH Insider Trading - FAQ
- What is the latest insider trade for CTTH?
- CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) had 0 insider filings in the last 90 days, with the most recent on 2025-11-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CTTH stock?
- 0 insider purchases of CTTH were filed in the last 90 days.
- How many insiders are selling CTTH stock?
- 0 insider sales of CTTH were filed in the last 90 days.
- Where can I see CTTH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CTTH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CV CapsoVision, Inc
- $CVKD Cadrenal Therapeutics, Inc.
- $CVM CEL SCI CORP
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
- $ERNA Ernexa Therapeutics Inc.
- $ETNB 89bio, Inc.
- $EWTX Edgewise Therapeutics, Inc.
- $FBIO Fortress Biotech, Inc.
- $GNPX Genprex, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CTTH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.